Table 2 Cardiac MRI findings in control and Duchenne muscular dystrophy (DMD) participants
From: Increased myocardial native T1 and extracellular volume in patients with Duchenne muscular dystrophy
| Â | Control | DMDa | p-value |
|---|---|---|---|
N = 11 | N = 31 | ||
LVEFb (%) | 60.3 ± 2.7 | 54.8 ± 8.1 | 0.033 |
Indexed LVEDVc (ml/m2) | 79.3 ± 11.0 | 63.8 ± 14.8 | 0.001 |
Indexed LVESVd (ml/m2) | 33.2 ± 4.8 | 29.4 ± 11.1 | 0.062 |
Indexed LV mass (g/m2) | 58.3 ± 8.0 | 53.2 ± 10.1 | 0.058 |
RVEFe (%) | 56.1 ± 3.4 | 56.6 ± 5.1 | 0.552 |
LGEf abnormal | 0 | 19 (61.3Â %) | <0.001# |
 Basal Anterior | 0 | 4 (12.9 %) |  |
 Basal Anteroseptal | 0 | 1 (3.2 %) |  |
 Basal Inferoseptal | 0 | 3 (9.7 %) |  |
 Basal Inferior | 0 | 12 (38.7 %) |  |
 Basal Inferolateral | 0 | 18 (58.1 %) |  |
 Basal Anterolateral | 0 | 18 (58.1 %) |  |
 Mid Anterior | 0 | 6 (19.4 %) |  |
Mid Anteroseptal | 0 | 3 (9.7Â %) | Â |
 Mid Inferoseptal | 0 | 5 (16.1 %) |  |
 Mid Inferior | 0 | 13 (41.9 %) |  |
 Mid Inferolateral | 0 | 17 (54.8 %) |  |
 Mid Anterolateral | 0 | 16 (51.6 %) |  |
 Apical Anterior | 0 | 5 (16.1 %) |  |
 Apical Septal | 0 | 6 (19.4 %) |  |
 Apical Inferior | 0 | 5 (16.1 %) |  |
 Apical Lateral | 0 | 7 (22.6 %) |  |
 Apex | 0 | 3 (9.7 %) |  |